215 related articles for article (PubMed ID: 30954619)
1. Multifunctional hyaluronate - nanoparticle hybrid systems for diagnostic, therapeutic and theranostic applications.
Kim H; Park Y; Stevens MM; Kwon W; Hahn SK
J Control Release; 2019 Jun; 303():55-66. PubMed ID: 30954619
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic Acid Derivatives for Translational Medicines.
Kim H; Shin M; Han S; Kwon W; Hahn SK
Biomacromolecules; 2019 Aug; 20(8):2889-2903. PubMed ID: 31251565
[TBL] [Abstract][Full Text] [Related]
3. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
Al-Jamal WT; Kostarelos K
Acc Chem Res; 2011 Oct; 44(10):1094-104. PubMed ID: 21812415
[TBL] [Abstract][Full Text] [Related]
4. Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics.
Nguyen KT; Zhao Y
Acc Chem Res; 2015 Dec; 48(12):3016-25. PubMed ID: 26605438
[TBL] [Abstract][Full Text] [Related]
5. Recent progress in theranostic applications of hybrid gold nanoparticles.
Gharatape A; Salehi R
Eur J Med Chem; 2017 Sep; 138():221-233. PubMed ID: 28668475
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional theranostic agents based on prussian blue nanoparticles for tumor targeted and MRI-guided photodynamic/photothermal combined treatment.
Lin X; Cao Y; Xue Y; Wu F; Yu F; Wu M; Zhu X
Nanotechnology; 2020 Mar; 31(13):135101. PubMed ID: 31783383
[TBL] [Abstract][Full Text] [Related]
7. Polysaccharide-based nanoparticles for theranostic nanomedicine.
Swierczewska M; Han HS; Kim K; Park JH; Lee S
Adv Drug Deliv Rev; 2016 Apr; 99(Pt A):70-84. PubMed ID: 26639578
[TBL] [Abstract][Full Text] [Related]
8. Biomineralization: An Opportunity and Challenge of Nanoparticle Drug Delivery Systems for Cancer Therapy.
Wang W; Liu X; Zheng X; Jin HJ; Li X
Adv Healthc Mater; 2020 Nov; 9(22):e2001117. PubMed ID: 33043640
[TBL] [Abstract][Full Text] [Related]
9. Development and characterisation of chondroitin sulfate- and hyaluronic acid-incorporated sorbitan ester nanoparticles as gene delivery systems.
Fernandez-Piñeiro I; Pensado A; Badiola I; Sanchez A
Eur J Pharm Biopharm; 2018 Apr; 125():85-94. PubMed ID: 29355685
[TBL] [Abstract][Full Text] [Related]
10. Biocompatible polymersomes-based cancer theranostics: Towards multifunctional nanomedicine.
Mohammadi M; Ramezani M; Abnous K; Alibolandi M
Int J Pharm; 2017 Mar; 519(1-2):287-303. PubMed ID: 28115259
[TBL] [Abstract][Full Text] [Related]
11. Progress in Nanotheranostics Based on Mesoporous Silica Nanomaterial Platforms.
Singh RK; Patel KD; Leong KW; Kim HW
ACS Appl Mater Interfaces; 2017 Mar; 9(12):10309-10337. PubMed ID: 28274115
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronate-Lipid Nanohybrids: Fruitful Harmony in Cancer Targeting.
Freag MS
Curr Pharm Des; 2017; 23(35):5283-5291. PubMed ID: 28552066
[TBL] [Abstract][Full Text] [Related]
13. Self-assembled hyaluronic acid nanoparticles: Implications as a nanomedicine for treatment of type 2 diabetes.
Rho JG; Han HS; Han JH; Lee H; Nguyen VQ; Lee WH; Kwon S; Heo S; Yoon J; Shin HH; Lee EY; Kang H; Yang S; Lee EK; Park JH; Kim W
J Control Release; 2018 Jun; 279():89-98. PubMed ID: 29649530
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronan-modified nanoparticles for tumor-targeting.
Sakurai Y; Harashima H
Expert Opin Drug Deliv; 2019 Sep; 16(9):915-936. PubMed ID: 31387408
[No Abstract] [Full Text] [Related]
15. Evaluation of intra-articular delivery of hyaluronic acid functionalized biopolymeric nanoparticles in healthy rat knees.
Zille H; Paquet J; Henrionnet C; Scala-Bertola J; Leonard M; Six JL; Deschamp F; Netter P; Vergès J; Gillet P; Grossin L
Biomed Mater Eng; 2010; 20(3):235-42. PubMed ID: 20930333
[TBL] [Abstract][Full Text] [Related]
16. Multiscale Imaging of Nanoparticle Drug Delivery.
Dobrucki LW; Pan D; Smith AM
Curr Drug Targets; 2015; 16(6):560-70. PubMed ID: 25642717
[TBL] [Abstract][Full Text] [Related]
17. Theranostic size-reducible and no donor conjugated gold nanocluster fabricated hyaluronic acid nanoparticle with optimal size for combinational treatment of breast cancer and lung metastasis.
Liu R; Xiao W; Hu C; Xie R; Gao H
J Control Release; 2018 May; 278():127-139. PubMed ID: 29630985
[TBL] [Abstract][Full Text] [Related]
18. Engineered Targeted Hyaluronic Acid-Glutathione-Stabilized Gold Nanoclusters/Graphene Oxide-5-Fluorouracil as a Smart Theranostic Platform for Stimulus-Controlled Fluorescence Imaging-Assisted Synergetic Chemo/Phototherapy.
Yang Y; Wang S; Wang C; Tian C; Shen Y; Zhu M
Chem Asian J; 2019 May; 14(9):1418-1423. PubMed ID: 30829452
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronate and its derivatives for customized biomedical applications.
Kim H; Jeong H; Han S; Beack S; Hwang BW; Shin M; Oh SS; Hahn SK
Biomaterials; 2017 Apr; 123():155-171. PubMed ID: 28171824
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Biomedical Applications of Multifunctional Nanoparticles.
Kim D; Shin K; Kwon SG; Hyeon T
Adv Mater; 2018 Dec; 30(49):e1802309. PubMed ID: 30133009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
